Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
The state of our nation – and the entire globe – has been turned upside down in light of the novel coronavirus COVID-19 pandemic. Many businesses are being forced to close their doors, or limit the services they provide and the ways they can offer them, for several weeks – or longer. These orders have come abruptly to most businesses, and many are struggling to find ways to cope.
U.S. President Donald Trump has sent “principles” for drug pricing reform to lawmakers, White House spokeswoman Stephanie Grisham said in a statement on Tuesday.
Most House Democrats who won Republican seats don’t support it. Even if Democrats win control of the Senate, they’ll be well short of a supermajority to overcome a filibuster.
Speaker Nancy Pelosi’s plan is aimed at distancing vulnerable Democrats from Medicare for All and other proposals being pushed by the party’s presidential contenders.
Insurers, state regulators and providers are demanding the Trump administration not change the automatic re-enrollment process for the Affordable Care Act’s (ACA's) exchanges.
Racing to confront a growing public health threat, the House resoundingly approved $8.3 billion in emergency aid on Wednesday to combat the novel coronavirus, hours after congressional leaders reached a deal on the funding.
The Supreme Court said Monday it would take up an appeal of a legal challenge to the 2010 health care law, teeing up a high-profile hearing on one of Democrats’ signature issues.
Senate Minority Leader Chuck Schumer on Sunday called for Medicare to cover the coronavirus vaccine, which is still being developed and is at least months away from being widely available.
If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release versions, billions in healthcare costs could be saved, a new study suggests.
As the Democratic primaries roll on and presidential candidates continue to attack the drug industry, one Republican senator is making a big push for his legislation.